Faculty Affiliates

Gilberto de Lima Lopes Junior, MD, MBA, FAMS

Associate Professor of Clinical Medicine
Medical Director for International Programs
Associate Director for Global Oncology
Co-Leader, Lung Cancer Site Disease Group
Sylvester Comprehensive Cancer Center
at the University of Miami and the Miller School of Medicine 

Gilberto Lopes, a medical oncologist, is the medical director for international programs and associate director for Global Oncology at the University of Miami Sylvester Comprehensive Cancer Center and associate professor at the Miller School of Medicine; and associate editor for ASCO University and for the society’s Journal of Global Oncology; he previously worked at the Johns Hopkins University and was chief medical and scientific officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr. Lopes has published more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, Nature Reviews, Lancet, Lancet Oncology and Health Affairs. In addition to delivering lectures around the world, he has been principal, co-Principal Investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary and thoracic cancers. His other main areas of research interest are health economics, value, policy and access to cancer drugs and treatment in low and middle income countries.

Dr. Lopes is currently a committee member for the International Association for the Study of Lung Cancer (IASLC), a member of the European Society of Medical Oncology expensive, innovative Medicines working group and the chair for the international clinical trials workshop working group and track leader for global health at the American Society of Clinical Oncology (ASCO), as well as an executive board member for the Latin American Cooperative Oncology Group (LACOG).

He has also served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization and advised governments, professional societies and industry on issues related to cancer control and treatment in low- and middle-income countries.

 

Erin Kobetz, Ph.D., M.P.H.

Dr. Erin Kobetz is a Tenured Professor in the Departments of Medicine, Public Health Sciences, Biochemistry, and Obstetrics and Gynecology at the University of Miami (UM) Miller School of Medicine. She is the School’s inaugural Senior Associate Dean for Health Disparities, and the Associate Director for Population Science and Cancer Disparity for the University of Miami Sylvester Comprehensive Cancer Center. Additionally, Dr. Kobetz serves as the Program Director for the Community Engagement and Multidisciplinary Team Science Components of the University of Miami’s Clinical Translational Science Institute (CTSA).

Dr. Kobetz earned a Master's in Public Health from Rollins School of Public Health at Emory University (1999), and joined UM in September 2004 after completing her Ph.D. at the University of North Carolina at Chapel Hill Gillings School of Public Health.

Soon after, Dr. Kobetz established Patnè en Aksyon (Partners in Action), the first campus-community partnership between the University of Miami and community-based organizations in Little Haiti, the largest enclave of Haitian settlement.  Dr. Kobetz serves as the Principal Investigator of multiple grants from the National Cancer Institute (NCI) and National Institute of Minority Health and Health Disparity (NIHMD) to support collaborative science with Patnè en Aksyon.  Collectively, they have garnered over 30 million dollars in extramural funding and serve as the University’s model for stakeholder engagement. Dr. Kobetz now collaborates with a number of other South Florida communities, similarly characterized by health disparity and lack of access to the formal healthcare system to develop new community-based models for cancer prevention.  She also leads University wide, interdisciplinary initiatives to address disparity from “bench” to “bedside” to “community.” Such efforts have been locally and nationally recognized and serve as an important strategy for working collaboratively with underserved communities to achieve sustainable health and social change.